✨ Free AI Report
Nanoform Finland Oyj: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Nanoform Finland Oyj
Company Research

Nanoform Finland Oyj: Business Overview, Financials & Competitive Analysis

Nanoform Finland Oyj scores 4/10 on the AskCyborg Cyborg Score (Mixed). Early-stage nanotechnology platform addressing significant pharma formulation challenges, but pre-profitable business model and execution risks require caution. While Nanoform operates in a high-value pharma niche with differentiated technology, the company faces significant profitability challenges with 2024 losses of €23.43M against modest revenue of €3.66M. Early-stage adoption and execution risk.

What is Nanoform Finland Oyj's industry? Nanoform Finland Oyj (nanoform.com) operates in Pharmaceutical Contract Development & Manufacturing (CDMO) / Nanotechnology Services. AskCyborg classifies Nanoform Finland Oyj under Pharmaceutical Contract Development & Manufacturing (CDMO) / Nanotechnology Services in its company registry.

Nanoform Finland is a nanoparticle medicine-enabling company providing advanced drug particle engineering services to pharma and biotech partners in Europe and North America. The company's proprietary Controlled Expan...

4/ 10Mixed

Cyborg Score thesis

Early-stage nanotechnology platform addressing significant pharma formulation challenges, but pre-profitable business model and...

Read the full analyst-debate transcript →
Industry Pharmaceutical Contract Development & Manufacturing (CDMO) / Nanotechnology Services
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Nanoform Finland Oyj Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Nanoform Finland Oyj

AskCyborg analysts argue the bull and bear cases for Nanoform Finland Oyj across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Nanoform Finland Oyj OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Nanoform Finland Oyj Overview

Pro stress-test →

Nanoform Finland is a nanoparticle medicine-enabling company providing advanced drug particle engineering services to pharma and biotech partners in Europe and North America. The company's proprietary Controlled Expansion of Supercritical Solutions (CESS) technology creates API nanoparticles as small as 10nm, enabling poorly soluble drugs to progress into clinical development by improving bioavailability and dissolution rates.

Strategic Profile

Pro stress-test →

Nanoform's competitive advantage lies in its patented, scalable CESS technology and emerging Nanoform Biologics platform for high-dose subcutaneous delivery of large molecules. The company positions itself to reduce clinical trial attrition and extend product lifecycles while serving a high-value pharma market where formulation enhancement drives significant differentiation.

Competitive Landscape

Pro stress-test →

Nanoform competes in the specialized pharmaceutical formulation services space against larger contract development and manufacturing organizations (CDMOs) and niche formulation specialists. Key competitive differentiation comes from proprietary CESS technology and growing biologics capabilities, though the market includes competitors offering alternative particle engineering and formulation solutions for similar pharma applications.

Industry Context

Nanoform Finland Oyj operates in Pharmaceutical Contract Development & Manufacturing (CDMO) / Nanotechnology Services.

Key facts

Founded: 2008 · Headquarters: Helsinki, Finland · Employees: 181 · Revenue: €3.66M · Market cap: €70M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Nanoform Finland Oyj.

  • Core CESS technology enables creation of nanoparticles as small as 10nm, directly addressing bioavailability challenges for poorly soluble pharmaceutical compounds
  • Emerging Nanoform Biologics platform demonstrates high-dose subcutaneous delivery capabilities, expanding addressable market beyond small molecules into large molecule therapeutics
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2025Successful development of nanotrastuzumab formulation for subcutaneous injection, demonstrating platform capability for biologics applications
  • 2024Revenue growth of 42.7% to €3.66M, though losses increased 12.9% to €23.43M, indicating scaling challenges
  • +1 moreTrack every material event for Nanoform Finland Oyj as it happens. Explore monitoring →
Get alerted when Nanoform Finland Oyj has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Particle Engineering ServicesGlobal CDMO with extensive formulation services→Formulation & DeliveryLarge CDMO with particle engineering capabilities→Specialty FormulationContract manufacturer with formulation services→

Compare Nanoform Finland Oyj with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Nanoform Finland Oyj operates in Pharmaceutical Contract Development & Manufacturing (CDMO) / Nanotechnology Services. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Contract Development & Manufacturing (CDMO) / Nanotechnology Services research →
NEW · MCP server

Ask your AI assistant about Nanoform Finland Oyj

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Nanoform Finland Oyj and its top competitor on Cyborg Score”
“What did Nanoform Finland Oyj do this quarter?”
“Is Nanoform Finland Oyj a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Nanoform Finland Oyj do?+
Nanoform Finland is a nanoparticle medicine-enabling company providing advanced drug particle engineering services to pharma and biotech partners in Europe and North America. The company's proprietary Controlled Expan...
What is Nanoform Finland Oyj's Cyborg Score?+
Nanoform Finland Oyj has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Nanoform Finland Oyj's main competitors?+
Named competitors include Particle Engineering Services, Formulation & Delivery, Specialty Formulation. The full competitive landscape is in the AskCyborg report.
How can I get the full Nanoform Finland Oyj research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Nanoform Finland Oyj research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Nanoform Finland Oyj over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.